Localized non‐Hodgkin's lymphoma of Waldeyer's ring: clinical features, management, and prognosis of 130 adult patients
AA Ezzat, EM Ibrahim, AN El Weshi… - Head & Neck …, 2001 - Wiley Online Library
Background Waldeyer's ring (WR) is the primary site of non‐Hodgkin's lymphoma (NHL)
involvement in approximately 5% to 10% of all lymphoma patients, and it accounts for more than …
involvement in approximately 5% to 10% of all lymphoma patients, and it accounts for more than …
Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors
…, AN El Weshi, AM Tulbah, MM Rahal, AA Ezzat - Acta …, 2006 - Taylor & Francis
Metaplastic carcinoma of the breast (MCB) is a rare form of cancer containing mixture of
epithelial and mesenchymal elements in variable combinations. Few and conflicting clinical data …
epithelial and mesenchymal elements in variable combinations. Few and conflicting clinical data …
The present and the future of breast cancer burden in the Kingdom of Saudi Arabia
Background Despite the low cancer incidence in the Kingdom of Saudi Arabia (KSA), the
country must be ready to face the challenge of foreseeable increase in cancer burden …
country must be ready to face the challenge of foreseeable increase in cancer burden …
Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population
AA Ezzat, EM Ibrahim, MA Raja, S Al-Sobhi, A Rostom… - Medical oncology, 1999 - Springer
In the Kingdom of Saudi Arabia (KSA), breast cancer constitutes 18% of all cancers in Saudi
women. Whilst locally advanced breast cancer disease is unusual in Western countries, it …
women. Whilst locally advanced breast cancer disease is unusual in Western countries, it …
Breast cancer in the eastern province of Saudi Arabia
…, FA Al-Mulhim, A Al-Amri, FA Al-Muhanna, AA Ezzat… - Medical oncology, 1998 - Springer
In the Kingdom of Saudi Arabia (KSA), hospital and population based statistics have shown
that breast cancer has the highest crude frequency rate among Saudi women. The scarcity of …
that breast cancer has the highest crude frequency rate among Saudi women. The scarcity of …
High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatin
AA Ezzat, EM Ibrahim, DS Ajarim, MM Rahal… - Breast cancer research …, 2000 - Springer
Background.In an earlier study, we have demonstrated a high response rate in metastatic
breast cancer using paclitaxel (P) and cisplatin (C). A phase II study using the same regimen (…
breast cancer using paclitaxel (P) and cisplatin (C). A phase II study using the same regimen (…
[PDF][PDF] Colorectal carcinoma from Saudi Arabia
KS Al-Kuraya, PP Bavi, AA Ezzat, FA Al-Dayel… - Saudi Med J, 2006 - academia.edu
Objective: To document the incidence and role of p53 and DNA mismatch repair proteins in
colorectal carcinomas, and to evaluate the relative frequency of major molecular pathways in …
colorectal carcinomas, and to evaluate the relative frequency of major molecular pathways in …
Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer
…, DM Fatani, GA El-Husseiny, NB Elkum, AA Ezzat - Medical Oncology, 2010 - Springer
The objective of this study is to evaluate the efficacy and safety profile of the doxorubicin
followed by cisplatin/docetaxel as primary chemotherapy for patients with locally advanced …
followed by cisplatin/docetaxel as primary chemotherapy for patients with locally advanced …
Adjuvant chemotherapy in 780 patients with early breast cancer: 10-year data from Saudi Arabia
EM Ibrahim, AA Ezzat, MM Rahal, MM Raja, DS Ajarim - Medical oncology, 2005 - Springer
Background: By and large, data about adjuvant chemotherapy for breast cancer in the Middle
East are lacking. Retrospective analysis of prospectively captured data from a main referral …
East are lacking. Retrospective analysis of prospectively captured data from a main referral …
HER-2/Neu overexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancer
AM Tulbah, EM Ibrahim, AA Ezzat, DS Ajarim… - Medical oncology, 2002 - Springer
Data about the prognostic and predictive value of HER-2/neu overexpression in patients
with locally advanced breast cancer (LABC) treated with primary chemotherapy is limited. …
with locally advanced breast cancer (LABC) treated with primary chemotherapy is limited. …